Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several key terms related to pembrolizumab and various medical classifications have been removed.
    Difference
    2%
    Check dated 2025-08-31T01:01:56.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T20:03:31.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T15:15:50.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated to a new version (v2.16.10), and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-02T14:09:11.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-07-26T12:14:16.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-19T10:54:24.000Z thumbnail image

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.